연구동향 분석

Contributed Mini Review : Naturally occurring reoviruses for human cancer therapy

( Manbok Kim ) 2015년

논문상세정보
인용/피인용
' Contributed Mini Review : Naturally occurring reoviruses for human cancer therapy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • attenuated reovirus
  • oncogene
  • oncolytic virus
  • reovirus
  • tumor suppressor gene
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
28 0

0.0%

' Contributed Mini Review : Naturally occurring reoviruses for human cancer therapy' 의 참고문헌

  • c-Myc, Genomic Instability and Disease
    Kuttler F Genome Dyn 1 : 171 ~ 190 [2006]
  • c-Myc : linking transformation and genomic instability
    Prochownik EV Curr Mol Med 8 : 446 ~ 458 [2008]
  • Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers
    Harrington KJ Clin Cancer Res 16 : 3067 ~ 3077 [2010]
  • Tumor suppressor-based susceptibility of hyperproliferative cells to oncolytic viral therapy
    Kim M Chinese patent No.: 200980126543.5 [2014]
  • The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status
    Kim M Oncogene 29 : 3990 ~ 3996 [2010]
  • The prevalence of antibodies to reovirus type 3 in adults with idiopathic cholestatic liver disease
    Minuk GY J Med Virol 16 : 55 ~ 60 [1985]
  • The preferential cytotoxicity of reovirus for certain transformed cell lines
    Hashiro G Arch Virol 54 : 307 ~ 315 [1977]
  • The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
    Alain T Br J Cancer 95 : 1020 ~ 1027 [2006]
  • The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus
    Strong JE EMBO J 17 : 3351 ~ 3362 [1998]
  • The ever expanding role for c-Myc in promoting genomic instability
    Prochownik EV Cell Cycle 6 : 1024 ~ 1029 [2007]
  • The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo
    Alkassar M J Neurooncol 104 : 715 ~ 727 [2011]
  • Synergistic interaction between oncolytic viruses augments tumor killing
    Le Boeuf F Mol Ther 18 : 888 ~ 895 [2010]
  • Studies on the pathogenesis of a hitherto undescribed virus(hepato-encephalomyelitis)producing unusual symptoms in suckling mice
    Stanley NF Aust J Exp Biol Med Sci 31 : 147 ~ 159 [1953]
  • Replicating poxviruses for human cancer therapy
    ( Manbok Kim ) The Journal of Microbiology 53 (4) : 209 ~ 218 [2015]
  • Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis
    Minuk GY J Hepatol 5 : 8 ~ 13 [1987]
  • Reovirus type 1 as an etiologic agent of the common cold
    Jackson GG Jour Clin Invest 40 : 1051 ~ [1961]
  • Reovirus therapy of tumors with activated Ras pathway
    Coffey MC Science 282 : 1332 ~ 1334 [1998]
  • Reovirus infections in human volunteers
    Rosen L Am J Hyg 77 : 29 ~ 37 [1963]
  • Reovirus and Tumor Oncolysis
    김만복 The Journal of Microbiology 45 (3) : 187 ~ 192 [2007]
  • Relationship of Hepatoencephalomyelitis Virus and Reoviruses
    Stanley NF letters to Nature 189 : 687 ~ [1961]
  • REO-10 : a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer
    Comins C Clin Cancer Res 16 : 5564 ~ 5572 [2010]
  • REO-001 : A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing(Reolysin®)in patients with advanced solid tumors
    Morris DG Invest New Drugs 31 : 696 ~ 706 [2013]
  • Phase II trial of intravenous administration of Reolysin(®)(Reovirus Serotype-3-dearing Strain)in patients with metastatic melanoma
    Galanis E Mol Ther 20 : 1998 ~ 2003 [2012]
  • Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies
    Karapanagiotou EM Clin Cancer Res 18 : 2080 ~ 2089 [2012]
  • Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults
    Kicielinski KP Mol Ther 22 : 1056 ~ 1062 [2014]
  • Naturally oncolytic viruses
    Roberts MS Curr Opin Mol Ther 8 : 314 ~ 321 [2006]
  • Morbidity in immunosuppressed(SCID/NOD)mice treated with reovirus(dearing 3)as an anticancer biotherapeutics
    Loken SD Cancer Biol Ther 3 : 734 ~ 738 [2004]
  • Isolation of a Non-pathogenic Tumour-destroying Virus from Mouse Ascites
    Bennette JG Nature 187 : 72 ~ 73 [1960]
  • Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture
    Ramos-Alvarez M Amer Jour Pub Health 46 : 295 ~ 299 [1956]
  • Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor
  • Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3
    Ramig RF J Virol 22 : 726 ~ 733 [1977]
  • Fields Virology
    Tyler KL Lippincott-Raven : 1729 ~ 1745 [2001]
  • Enteropathogenic viruses and bacteria. Role in summer diarrheal diseases of infancy and early childhood
    Ramos-Alvarez M Jour Amer Med Ass'n 167 : 147 ~ 156 [1958]
  • Drug evaluation:Reolysin--wild-type reovirus as a cancer therapeutics
    Stoeckel J Curr Opin Mol Ther 8 : 249 ~ 260 [2006]
  • Differential sensitivity of normal and transformed human cells to reovirus infection
    Duncan MR J Virol 28 : 444 ~ 449 [1978]
  • Chromosome instability and deregulated proliferation: an unavoidable duo
    Coschi CH Cell Mol Life Sci 69 : 2009 ~ 2024 [2012]
  • Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children
    Ramos-Alvarez M Proc Soc Exp Biol Med 87 : 655 ~ 661 [1954]
  • Characteristics of a newborn runt disease induced by neonatal infection with an oncolytic strain of reovirus type 3(REO3MH). I. Pathological investigations in rats and mice
    Bennette JG Br J Exp Pathol 48 : 251 ~ 266 [1967]
  • Cancer drug resistance: an evolving paradigm
    Holohan C Nat Rev Cancer 13 : 714 ~ 726 [2013]
  • Attenuated reovirus displays oncolysis with reduced host toxicity
    Kim M Br J Cancer 104 : 290 ~ 299 [2011]
  • An Oncolytic Virus recovered from Swiss Mice during Passage of an Ascites Tumour
    Nelson JB Nature 188 : 866 ~ 867 [1960]
  • All reovirus subtypes show oncolytic potential in primary cells of human high-grade glioma
    Alloussi SH Oncol Rep 26 : 645 ~ 649 [2011]
  • Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells
    Kim M Oncogene 26 : 4124 ~ 4134 [2007]
  • A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas
    Forsyth P Mol Ther 16 : 627 ~ 632 [2008]
  • A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer
    Lolkema MP Clin Cancer Res 17 : 581 ~ 588 [2011]
  • A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer
    Vidal L Clin Cancer Res 14 : 7127 ~ 7137 [2008]
  • A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described
    Sabin AB. Science 130 : 1387 ~ 1389 [1959]